These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28990510)

  • 1. Benzothiazole-based Compounds in Antibacterial Drug Discovery.
    Gjorgjieva M; Tomašič T; Kikelj D; Mašič LP
    Curr Med Chem; 2018; 25(38):5218-5236. PubMed ID: 28990510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green synthesis and biological evaluation of 6-substituted-2-(2-hydroxy/methoxy phenyl)benzothiazole derivatives as potential antioxidant, antibacterial and antitumor agents.
    Racané L; Ptiček L; Fajdetić G; Tralić-Kulenović V; Klobučar M; Kraljević Pavelić S; Perić M; Paljetak HČ; Verbanac D; Starčević K
    Bioorg Chem; 2020 Jan; 95():103537. PubMed ID: 31884142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on the Developments of Benzothiazole-containing Antimicrobial Agents.
    Haroun M
    Curr Top Med Chem; 2022; 22(32):2630-2659. PubMed ID: 36503470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of a novel series of 2,3-diaryl-substituted-imidazo(2,1-b)-benzothiazole derivatives.
    Palkar M; Noolvi M; Sankangoud R; Maddi V; Gadad A; Nargund LV
    Arch Pharm (Weinheim); 2010 Jun; 343(6):353-9. PubMed ID: 20397211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial evaluation of a novel series of 2-(1,2-dihydro-3-oxo-3H-pyrazol-2-yl)benzothiazoles.
    Stella A; Segers K; De Jonghe S; Vanderhoydonck B; Rozenski J; Anné J; Herdewijn P
    Chem Biodivers; 2011 Feb; 8(2):253-65. PubMed ID: 21337499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
    Zhang J; Ba Y; Wang S; Yang H; Hou X; Xu Z
    Eur J Med Chem; 2019 Oct; 179():376-388. PubMed ID: 31260891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of in vitro time point quantitative evaluation of newly synthesized benzimidazole and benzothiazole derivatives as potential antibacterial agents.
    Bandyopadhyay P; Sathe M; Ponmariappan S; Sharma A; Sharma P; Srivastava AK; Kaushik MP
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7306-9. PubMed ID: 22047695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.
    Reshma RS; Jeankumar VU; Kapoor N; Saxena S; Bobesh KA; Vachaspathy AR; Kolattukudy PE; Sriram D
    Bioorg Med Chem; 2017 May; 25(10):2761-2771. PubMed ID: 28389113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
    Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
    Thakkar SS; Thakor P; Ray A; Doshi H; Thakkar VR
    Bioorg Med Chem; 2017 Oct; 25(20):5396-5406. PubMed ID: 28789907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly.
    Chauhan J; Yu W; Cardinale S; Opperman TJ; MacKerell AD; Fletcher S; de Leeuw EP
    Drug Des Devel Ther; 2020; 14():567-574. PubMed ID: 32103898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.
    Landge S; Mullick AB; Nagalapur K; Neres J; Subbulakshmi V; Murugan K; Ghosh A; Sadler C; Fellows MD; Humnabadkar V; Mahadevaswamy J; Vachaspati P; Sharma S; Kaur P; Mallya M; Rudrapatna S; Awasthy D; Sambandamurthy VK; Pojer F; Cole ST; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M; Ramachandran V
    Bioorg Med Chem; 2015 Dec; 23(24):7694-710. PubMed ID: 26643218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
    Narender M; Jaswanth S B; Umasankar K; Malathi J; Raghuram Reddy A; Umadevi KR; Dusthackeer AVN; Venkat Rao K; Raghuram R A
    Bioorg Med Chem Lett; 2016 Feb; 26(3):836-840. PubMed ID: 26755393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
    Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.